Appl Resch in Clinical and Rehabilitative Medicine
Abstract
This project identifies and evaluates drugs, biologics (products derived from living organisms), medical devices, treatments and diagnostics for post-evacuation restorative, regenerative and rehabilitative care, as well as systems for use by field medics and surgeons for ocular trauma. Research focus is on identifying more effective technologies and protocols to treat ocular injury and visual system dysfunction, as well as laboratory and animal studies for regenerating skin, muscle, nerves, vascular and bone tissues for the care and treatment of traumatic injury. This project is being coordinated with the Defense Health Program. Research involves extensive collaboration with multiple academic institutions to refine treatments for combat wounds through Armed Forces Institute of Regenerative Medicine (AFIRM). This project is coordinated with the Military Departments and other government organizations to avoid duplication. Research conducted in this project focuses on Clinical and Rehabilitative Medicine. All drugs, biological products, and medical devices are refined in accordance with Food and Drug Administration (FDA) regulations, which govern testing in animals to assess safety, toxicity, and effectiveness and subsequent human subject clinical trials. Promising efforts identified in this project are further matured under Program Element (PE) 0603002A, Project ET5. The cited work is consistent with the Assistant Secretary of Defense, Research and Engineering Science and Technology, focus areas and the Army Modernization Strategy. Work on this project is performed by United States Army Institute of Surgical Research (USAISR), Joint Base San Antonio, TX; and the AFIRM, at Multiple Institutions across the United States.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2017
- Source ID
- ET4_0602787A_2_2040_PB_2017
Related Documents
- Root: Medical Technology
- Child Accomplishment: Clinical and Rehabilitative Medicine